Stock listing
NASDAQ:TRDA Entrada Therapeutics, Inc. Stock
Home listing (NASDAQ) of Entrada Therapeutics, Inc.
Follow Entrada Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:TRDA
$4.78 USD +0.23 (+5.1%)
Close on Oct 15, 2026
- Ticker
- NASDAQ:TRDA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 14, 2026
Entrada Therapeutics Announces Positive Results from the First Cohort of Participants with Duchenne Muscular Dystrophy (DMD) in the Phase 1/2 ELEVATE-45-201 Study of ENTR-601-45
Latest deck · August 2026
Investor Presentation (August 2026)
Investor deck · 50 slides
Latest news
Decks
Investor Presentation (August 2026)
Investor deck · 50 slides · August 2026
Investor Presentation (May 2026)
Investor deck · 51 slides · May 19, 2026
2025 J.P. Morgan Healthcare Conference
Conference · 25 slides · Jan 15, 2025
Entrada Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 14 in the last 12 months · 72 in all · newest Oct 14, 2026 · oldest 2021
- Decks
- 3 decks · latest August 2026
Where Entrada Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:TRDA · Home listing · This page | NASDAQ | United States | USD |
| BOATS:TRDA | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Entrada Therapeutics, Inc.